Atjaunināt sīkdatņu piekrišanu

E-grāmata: Pancreatic Disease: Basic Science and Clinical Management

  • Formāts: PDF+DRM
  • Izdošanas datums: 05-Jun-2013
  • Izdevniecība: Springer London Ltd
  • Valoda: eng
  • ISBN-13: 9781852339043
  • Formāts - PDF+DRM
  • Cena: 154,06 €*
  • * ši ir gala cena, t.i., netiek piemērotas nekādas papildus atlaides
  • Ielikt grozā
  • Pievienot vēlmju sarakstam
  • Šī e-grāmata paredzēta tikai personīgai lietošanai. E-grāmatas nav iespējams atgriezt un nauda par iegādātajām e-grāmatām netiek atmaksāta.
  • Formāts: PDF+DRM
  • Izdošanas datums: 05-Jun-2013
  • Izdevniecība: Springer London Ltd
  • Valoda: eng
  • ISBN-13: 9781852339043

DRM restrictions

  • Kopēšana (kopēt/ievietot):

    nav atļauts

  • Drukāšana:

    nav atļauts

  • Lietošana:

    Digitālo tiesību pārvaldība (Digital Rights Management (DRM))
    Izdevējs ir piegādājis šo grāmatu šifrētā veidā, kas nozīmē, ka jums ir jāinstalē bezmaksas programmatūra, lai to atbloķētu un lasītu. Lai lasītu šo e-grāmatu, jums ir jāizveido Adobe ID. Vairāk informācijas šeit. E-grāmatu var lasīt un lejupielādēt līdz 6 ierīcēm (vienam lietotājam ar vienu un to pašu Adobe ID).

    Nepieciešamā programmatūra
    Lai lasītu šo e-grāmatu mobilajā ierīcē (tālrunī vai planšetdatorā), jums būs jāinstalē šī bezmaksas lietotne: PocketBook Reader (iOS / Android)

    Lai lejupielādētu un lasītu šo e-grāmatu datorā vai Mac datorā, jums ir nepieciešamid Adobe Digital Editions (šī ir bezmaksas lietotne, kas īpaši izstrādāta e-grāmatām. Tā nav tas pats, kas Adobe Reader, kas, iespējams, jau ir jūsu datorā.)

    Jūs nevarat lasīt šo e-grāmatu, izmantojot Amazon Kindle.

Pancreatic Disease: Basic Science and Clinical Management summarises the state of the art in basic science and clinical management of pancreatic disease. This book provides a clear and up-to-date review of the advancing areas in clinical pancreatology and clinical research related to the pancreas. Written by leading experts in the field, this comprehensive review directs the interested reader towards important and current published source material.



Covering all aspects of pancreatic disease, contributions are included from pancreatic surgeons and medical pancreatologists on pancreatic cancer, acute pancreatitis and chronic pancreatitis. Special features include a systematic review of the evidence for the use of gemcitabine in pancreatic cancer prepared for the National Institute of Clinical Excellence (NICE), the UK body charged with evaluating new drug treatment. Gemcitabine has FDA approval. There are several contributions dealing with the management of pancreatic neuroendocrine tumours.



This book will be useful to gastroenterologists, internists and surgeons, and specialist clinicians with an interest in pancreatic disease. Trainees in medical and surgical pancreatology will find it a companion to supplement standard textbooks.

Papildus informācija

Springer Book Archives
1 Epidemiology of Pancreatic Neuroendocrine Tumours.- 2 Quality of Life
Issues Identified by Healthcare Workers and Patients with Metastatic
Carcinoid/Neuroendocrine Tumours.- 3 Diagnosis and Localisation of
Insulinoma.- 4 GI Hormone Producing Tumours: Syndromes and Treatment
Options.- 5 Progress by Collaboration: ESPAC Studies.- 6 Gemcitabine: a
Systematic Review.- 7 Farnesyl Protein Transferase Inhibitors in Pancreatic
Cancer.- 8 Novel Alternatives to Chemotherapy in Advanced Disease: Gastrin
Antibodies.- 9 Novel Alternatives to Chemotherapy in Advanced Disease: Gene
Transfer.- 10 Suicide Gene Therapy for Pancreatic Cancer.- 11 Pancreatic
Cystic Lesions and Neoplasms.- 12 Pancreatic Involvement in Von Hippel-Lindau
Disease.- 13 Intraductal Papillary Mucinous Tumours of the Pancreas.- 14
Endoscopic Ultrasound in the Diagnosis of Chronic Pancreatitis and Pancreatic
Cancer.- 15 Natural Course of Chronic Pancreatitis.- 16 Autoimmune
Pancreatitis.- 17 Whats New in Pancreatic Stellate Cell Biology?.- 18
Pancreatic Stellate Cells and their Role in Fibrogenesis.- 19 Factors
Influencing Pancreatic Stellate Cell Phenotype and Cell Turnover.- 20
Acinar-Islet Cell Interactions: Diabetes Mellitus in Chronic Pancreatitis.-
21 Acinar-Islet Interactions: Pancreatic Exocrine Insufficiency in Diabetes
Mellitus.- 22 Genetic Basis of Hereditary and Sporadic Pancreatitis.- 23
Cytokines in Chronic Pancreatitis.- 24 Cytokine Gene Polymorphisms in Acute
Pancreatitis.- 25 Genetic Polymorphism, the Immune Response and Chronic
Pancreatitis.- 26 Xenobiotic Metabolising Enzymes in Pancreatitis.- 27
Trypsin Activation and Inhibition in Pancreatitis.- 28 Selecting Patients for
Trials and Treatment: Apache-II?.- 29 Selecting Severe Cases of Acute
Pancreatitis for Trials and for Treatment: Enzymesand Activation Peptides.-
30 Selecting Severe Cases of Acute Pancreatitis on the Basis of Organ
Failure.- 31 Individual Features Related to Severity in Acute Pancreatitis.-
32 Sterile Necrosis in Acute Necrotizing Pancreatitis: Current Concepts and
Management Strategies.- 33 Management of Infected Pancreatic Necrosis.- 34
Antibiotics in Acute Pancreatitis.- 35 Enteral Nutrition in Acute
Pancreatitis: Mucosal Barrier.- 36 Early Enteral Nutrition and Markers of the
Inflammatory Response in Severe Acute Pancreatitis.- 37 Enteral Nutrition in
Acute Pancreatitis: Clinical Outcome.- 38 Measurement of Symptoms and Quality
of Life in Pancreatic Disease.- 39 Mechanism of Nociception in Chronic
Pancreatitis.- 40 Bilateral Thoracoscopic Splanchnicectomy in the Management
of Pain in Patients with Chronic Pancreatitis.- 41 Nerve Pathways for Pain.-
42 Pain Management in Chronic Pancreatitis.- 43 Pancreatic Decompression in
Chronic Pancreatitis.